Quantcast

Latest pharmaceutical industry Stories

2014-06-10 23:03:31

The GlaxoSmithKline settlement involves the District of Columbia and 44 states over the marketing of Advair, Paxil, and Wellbutrin. Port Washington, NY (PRWEB) June 10, 2014 Parker Waichman LLP, a national law firm representing the victims of defective drugs is commenting on a recent settlement by drug maker, GlaxoSmithKline, over allegations involving the way in which Advair, Paxil, and Wellbutrin were marketed and how the drugs were promoted for off-label uses. According to a The...

2014-06-10 16:27:52

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Antibody Partnering Terms and Agreementshttp://www.reportbuyer.com/countries/north_america/usa/antibody_partnering_terms_agreements.html The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.The Antibody Partnering Terms and...

2014-06-10 16:27:18

SOUTH PLAINFIELD, N.J., June 10, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 9, 2014 it approved non-statutory stock options to purchase an aggregate of 23,950 shares of its common stock to eight new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of our new hires' employment compensation. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO The inducement grants were approved by PTC's...

2014-06-10 12:30:38

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Fibrosis - Pipeline Review, H1 2014http://www.reportbuyer.com/pharma_healthcare/treatments/fibrosis_pipeline_review_h1_2013.html Fibrosis - Pipeline Review, H1 2014SummaryGlobal Markets Direct's, 'Fibrosis - Pipeline Review, H1 2014', provides an overview of the Fibrosis's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Fibrosis, complete...

2014-06-10 12:29:53

BOSTON, June 10, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that several of its experts will discuss a broad range of key issues facing the industry at the 50(th) Annual Drug Information Association (DIA) Meeting, held from June 15 to 19, 2014 in San Diego. "PAREXEL has a broad range of global expertise on issues encompassing the full spectrum of today's drug development journey," said Josef von...

2014-06-10 08:31:46

- Veteran of animal health brings depth of expertise to Merial's R&D organization - LYON, France, June 10, 2014 /PRNewswire/ -- Merial, the animal health division of Sanofi, today announced that Fabian Kausche will be leading the company's global research and development (R&D) efforts, effective June 9, 2014. Dr. Kausche brings to the company a wide range of global experience in pharmaceutical and biological R&D and business leadership positions, at both human and animal...

2014-06-10 08:31:42

DOYLESTOWN, Pa., June 10, 2014 /PRNewswire/ -- On June 2, 2014 Makindus, Inc. a specialty pharmaceutical company, received orphan drug designation for their lead product MI-100 from the U.S. Food and Drug Administration Office of Orphan Products Development for the treatment of Stargardt's Disease. "The FDA's approval of our orphan drug designation application for MI-100 to treat Stargardt's disease is a key milestone for the company and we look forward to initiating our Phase 3...

2014-06-10 08:31:06

First Site Opened In Late May, 7 More Sites Now Scheduled During June and July BETHESDA, Md., June 10, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that it has initiated the Phase III trial of DCVax-L in Germany. The first site to open in Germany was a medical center in Dresden, which was initiated in late May. The Company has now scheduled the...

2014-06-10 08:30:46

NEW YORK, June 10, 2014 /PRNewswire/ -- Intralinks® Holdings, Inc. (NYSE: IL), a leading, global SaaS provider of inter-enterprise content management and collaboration solutions, today announced the availability of its electronic investigator-controlled site file (eISF) solution, a simple online document storage tool for investigator sites involved in the clinical trial process. The new solution is designed to dramatically improve regulatory compliance and efficiency at the...

2014-06-10 08:30:11

NASDAQ: CRME TSX: COM VANCOUVER, June 10, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that pursuant to the increase in size of the Board of Directors to six members, as disclosed in the 2014 information circular, an additional director nominee will be included at its 2014 Annual General and Special Meeting of Shareholders held on June 16, 2014. The Company is pleased to announce the nomination of W. James O'Shea to the Board of...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.